Skip to main content

CORRECTION article

Front. Immunol., 26 February 2024
Sec. Mucosal Immunity

Corrigendum: The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD

  • 1Laboratory of Innate Immunity, Program of Immunology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile
  • 2Immunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, Netherlands
  • 3Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, Netherlands
  • 4Laboratory of Metabolic Plasticity and Bioenergetics, Program of Molecular and Clinical Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile
  • 5Laboratory of Biomedicine Research, School of Medicine, Universidad Finis Terrae, Santiago, Chile

A Corrigendum on:
The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD

By Astorga J, Gasaly N, Dubois-Camacho K, De la Fuente M, Landskron G, Faber KN, Urra FA and Hermoso MA (2022) Front. Immunol. 13:1028953. doi: 10.3389/fimmu.2022.1028953

In the published article, there was an error in the legend for

Table 1 Dietary phytochemicals and their restorative effects on mitochondrial function and lipid homeostasis as published. ↓ increase; ↑ decrease (on table footnotes). The corrected legend appears below.

Table 1
www.frontiersin.org

Table 1 Dietary phytochemicals and their restorative effects on mitochondrial function and lipid homeostasis.

[↑ increase; ↓ decrease]

In the published article, there was an error in the Funding statement. This work was funded by the Agencia Nacional de Investigación y Desarrollo (ANID)/PhD fellowship #21220889 (JA), and #21200669 (NG), FONDECYT Grants #1120702 (MAH), #11201322 (FAU), MiBi: interdisciplinary group on mitochondrial targeting and bioenergetics ACT 210097 (FAU); FONDECYT postdoctoral grant #3210367 (KD-C). The correct Funding statement appears below.

FUNDING

This work was funded by the Agencia Nacional de Investigación y Desarrollo (ANID)/PhD fellowship #21220889 (JA), and #21200669 (NG), FONDECYT Grants #1220702 (MAH), #11201322 (FAU), MiBi: interdisciplinary group on mitochondrial targeting and bioenergetics ACT 210097 (FAU); FONDECYT postdoctoral grant #3210367 (KD-C).

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: IBD - inflammatory bowel disease, intracellular cholesterol accumulation, mitochondrial dysfunction, inflammasome, NLRP3 inflammasome, diet phytochemicals

Citation: Astorga J, Gasaly N, Dubois-Camacho K, De la Fuente M, Landskron G, Faber KN, Urra FA and Hermoso MA (2024) Corrigendum: The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD. Front. Immunol. 15:1384162. doi: 10.3389/fimmu.2024.1384162

Received: 08 February 2024; Accepted: 12 February 2024;
Published: 26 February 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Astorga, Gasaly, Dubois-Camacho, De la Fuente, Landskron, Faber, Urra and Hermoso. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Marcela A. Hermoso, mhermoso@med.uchile.cl; m.a.hermoso@umcg.nl

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.